Discover Verapamil, a calcium channel blocker used for hypertension, angina, and arrhythmias. Learn about its dosage, side effects, and benefits for cardiovascular health.
Browse our catalog for available pharmaceutical products and competitive pricing.
Verapamil is a pharmaceutical compound classified as a non-dihydropyridine calcium channel blocker. It is widely utilized in cardiology for the management of various cardiovascular conditions, primarily hypertension, angina pectoris, and certain types of cardiac arrhythmias. First synthesized in 1962, Verapamil was among the pioneering calcium channel blockers to be introduced into clinical practice, marking a significant advancement in the treatment of heart-related ailments. Its discovery opened new avenues for understanding and modulating cardiac function, offering a safer and more effective alternative to some existing therapies at the time.
The drug's mechanism of action involves inhibiting the influx of calcium ions into cardiac and vascular smooth muscle cells, leading to a reduction in myocardial contractility, peripheral vascular resistance, and heart rate. This comprehensive effect makes Verapamil a versatile agent in managing conditions where these physiological parameters need careful control. Its introduction revolutionized the approach to cardiovascular disease, providing clinicians with a potent tool to improve patient outcomes and quality of life.
As a member of the phenylalkylamine class of calcium channel blockers, Verapamil stands distinct from dihydropyridine calcium channel blockers (like amlodipine) due to its more pronounced effects on cardiac conduction and contractility, in addition to its vasodilatory properties. It is designated by the Anatomical Therapeutic Chemical (ATC) classification system with the code C08DA01, falling under C08 (Calcium channel blockers) and specifically C08D (Phenylalkylamine derivatives). This classification reflects its primary action and chemical structure, distinguishing it within the broader category of cardiovascular medications.
The therapeutic efficacy of Verapamil stems from its ability to selectively block voltage-gated L-type calcium channels, predominantly found in the heart and smooth muscle cells of blood vessels. By binding to a specific site on these channels, Verapamil prevents the influx of extracellular calcium ions into the cell. This action is crucial because calcium influx is a fundamental step in initiating muscle contraction and electrical signal propagation in the heart. In cardiac muscle, reduced calcium entry leads to decreased myocardial contractility (negative inotropy) and a slower heart rate (negative chronotropy) by slowing depolarization in the sinoatrial (SA) and atrioventricular (AV) nodes.
Furthermore, the blockade of calcium channels in vascular smooth muscle cells results in vasodilation, particularly in the peripheral arteries. This relaxation of arterial smooth muscle reduces systemic vascular resistance, thereby lowering arterial blood pressure. The combined effects of reduced cardiac workload, decreased heart rate, and peripheral vasodilation contribute to Verapamil's effectiveness in treating hypertension and angina. Its impact on the AV node is particularly beneficial in managing supraventricular tachyarrhythmias by prolonging the refractory period and slowing conduction velocity, thus helping to restore normal heart rhythm.
Verapamil is a highly effective medication prescribed for a range of cardiovascular conditions due to its multifaceted actions on the heart and blood vessels. Its ability to modulate heart rate, reduce cardiac workload, and lower blood pressure makes it a cornerstone in the management of chronic and acute cardiac disorders. Treatment with Verapamil typically aims to alleviate symptoms, prevent disease progression, and improve overall cardiovascular function.
The dosage of Verapamil is highly individualized, depending on the specific condition being treated, the patient's age, weight, renal and hepatic function, and response to therapy. It is available in various formulations, including immediate-release tablets, extended-release tablets, and intravenous injections. Careful titration is often required to achieve optimal therapeutic effects while minimizing side effects. It is crucial never to self-adjust the dose of Verapamil without explicit instructions from a healthcare provider.
| Indication | Typical Dose | Frequency | Route |
|---|---|---|---|
| Hypertension | 80-120 mg (immediate-release) | 2-3 times daily | Oral |
| Angina Pectoris | 80-120 mg (immediate-release) | 3 times daily | Oral |
| Supraventricular Tachycardia | 5-10 mg | Single dose, may repeat once | Intravenous |
| Atrial Fibrillation/Flutter (Rate Control) | 180-480 mg (extended-release) | Once daily | Oral |
Important: Always follow your prescriber instructions. Dosages vary by weight, age, and condition.
Like all medications, Verapamil can cause side effects, although not everyone experiences them. The incidence and severity of side effects are often dose-dependent and can vary significantly among individuals. It is important to discuss any concerns with your healthcare provider.
Verapamil is metabolized by the cytochrome P450 3A4 (CYP3A4) enzyme system and is also an inhibitor of this enzyme and P-glycoprotein. This makes it prone to numerous significant drug interactions that can alter the levels and effects of Verapamil or other co-administered medications. Patients should always inform their doctor and pharmacist about all medications, supplements, and herbal products they are taking.
Verapamil is a powerful medication and is not suitable for everyone. Certain medical conditions or situations contraindicate its use due to the risk of serious adverse effects. Always ensure your healthcare provider is aware of your full medical history before initiating treatment with Verapamil.
Medical Disclaimer: This information is for educational purposes only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.
Yes, Verapamil is generally considered safe and effective for long-term management of chronic conditions such as hypertension and angina, provided it is taken as prescribed and under regular medical supervision. Long-term use requires periodic monitoring of blood pressure, heart rate, and kidney/liver function to ensure continued efficacy and to detect any potential adverse effects. Patients should not discontinue Verapamil abruptly without consulting their doctor, as this can lead to rebound symptoms or worsening of their underlying condition.
Verapamil can generally be taken with or without food. However, taking it with food may help reduce gastrointestinal side effects such as stomach upset or nausea, which some individuals might experience. For extended-release formulations, consistency in taking the medication (e.g., always with food or always without food) at the same time each day is often recommended to maintain stable drug levels. Always follow the specific instructions provided by your pharmacist or doctor regarding food intake with your particular Verapamil formulation.
If you miss a dose of Verapamil, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one, as this can increase the risk of side effects. If you frequently miss doses or are unsure about what to do, contact your healthcare provider or pharmacist for advice.
Verapamil is a prescription-only medication. This means it cannot be purchased over-the-counter and requires a valid prescription from a licensed healthcare professional. You can obtain Verapamil from a licensed pharmacy after your doctor has assessed your condition and determined that it is an appropriate treatment for you. It is crucial to obtain all prescription medications through legitimate and regulated medical channels to ensure their authenticity, safety, and proper dispensing.